The Misleading "Pooled Effect Estimate" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19)

Journal article

Open access

Peer reviewed

Clinical infectious diseases, Vol.72(12), pp.E1154-E1155

15/06/2021

PMID: 33201228

Abstract

Immunology

Infectious Diseases

Life Sciences & Biomedicine

Microbiology

Science & Technology

url

https://doi.org/10.1093/cid/ciaa1735View

Published (Version of record) Open

1 Record Views

Title: The Misleading "Pooled Effect Estimate" of Crude Data from Observational Studies at Critical Risk of Bias: The Case of Tocilizumab in Coronavirus Disease 2019 (COVID-19)
Creators - without role: Imad M. Tleyjeh - King Fahd Medical City
Publication Details: Clinical infectious diseases, Vol.72(12), pp.E1154-E1155
Publisher: Oxford Univ Press
Number of pages: 2
Identifiers: 9913873208331
Academic Unit: Alfaisal University
Language: English
Resource Type: Journal article